HAYWARD, Calif., June 12, 2013 /PRNewswire/ -- Solta Medical, Inc.
(NASDAQ: SLTM), a global leader in the medical aesthetics market,
today announced that its Board of Directors has elected
Mark M. Sieczkarek as its Chairman.
Mr. Sieczkarek has been a member of the Board of Directors since
July 2006 and has served as lead
director since January 2008. He has more than 18 years of
leadership experience in the medical device industry and served as
President and CEO of Conceptus, Inc. from 2003 to 2011. Mr.
Sieczkarek succeeds Stephen J.
Fanning, who remains as President and Chief Executive
Officer of Solta Medical.
"As part of our regular review of corporate governance and best
practices, our Board of Directors has decided to separate the roles
of Chairman and CEO," said Linda
Graebner, Chairman of the Board's Nominating and Governance
Committee. "In electing Mark our Chairman, our shareholders
will benefit from his previous public company experience as well as
his seven years of service on Solta's Board of Directors. At the
same time, we believe that this transition will enable Steve, our
President and CEO, to focus on executing the plan to drive growth
and returns from the Company's operations."
"From all perspectives, Solta has emerged as a leader in the
growing aesthetics industry and our growth requires the Company to
evolve in order to maximize the potential for shareholders,
customers and employees," said Mr. Sieczkarek. "I deeply
appreciate the Board's confidence in electing me their chairman and
look forward to working with the rest of the organization to
realize the full potential of Solta Medical."
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative solutions with proven efficacy and
safety backed by over 10 years of clinical study and research. The
company offers aesthetic energy devices for skin resurfacing and
rejuvenation, acne reduction, body contouring and skin tightening,
as well as tools and accessories to optimize the latest liposuction
techniques. The Solta Medical portfolio includes the well-known
brands Thermage®, Fraxel®, Clear + Brilliant®,
Liposonix®, Isolaz®, CLARO®,
VASERlipo™, VASERshape™, VASERsmooth™,
VentX®, PowerX®, TouchView®, and
Origins™, which collectively make up a comprehensive
platform to address a range of aesthetic skin and body issues. More
than two and a half million procedures have been performed with
Solta Medical's products around the world. Solta Medical is
headquartered in Hayward, CA with
field teams and regional offices worldwide.
SOURCE Solta Medical, Inc.